Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
semaglutide
Locations
1
Hong Kong
The University of Hong Kong, Department of Medicine
Hong Kong, Hong Kong
Start Date
March 20, 2025
Primary Completion Date
July 31, 2026
Completion Date
January 31, 2027
Last Updated
May 13, 2025
NCT07311850
NCT07049861
NCT06623669
NCT06976307
NCT06636773
NCT06878989
Lead Sponsor
The University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions